E. V. van Gorp

发表

Quantification of HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in peripheral blood mononuclear cell lysate using liquid chromatography coupled with tandem mass spectrometry.

H. Rosing, J. Beijnen, R. ter Heine, 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Serological Evidence of Human Hantavirus Infections in Indonesia

A. Osterhaus, Å. Lundkvist, J. Groen, 2002, Infection.

Drug interaction between St John's wort and nevirapine.

J. Beijnen, R. Mathôt, E. V. van Gorp, 2001, AIDS.

Kinetics of Dengue Virus-Specific Serum Immunoglobulin Classes and Subclasses Correlate with Clinical Outcome of Infection

A. Osterhaus, C. Hack, J. Groen, 2001, Journal of Clinical Microbiology.

Quantification of protease inhibitors and non-nucleoside reverse transcriptase inhibitors in dried blood spots by liquid chromatography-triple quadrupole mass spectrometry.

H. Rosing, J. Beijnen, A. Huitema, 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

What role do coagulation disorders play in the pathogenesis of leptospirosis?

H. ten Cate, R. Hartskeerl, M. H. Gasem, 2006, Tropical medicine & international health : TM & IH.

A highly virulent variant of HIV-1 circulating in the Netherlands

Michael J. Rausch, H. Jessen, A. Trkola, 2022, Science.

Review: infectious diseases and coagulation disorders.

J. T. ten Cate, J. V. D. van der Meer, H. ten Cate, 1999, The Journal of infectious diseases.

Population pharmacokinetics of lopinavir in combination with ritonavir in HIV-1-infected patients.

J. Beijnen, J. Mulder, B. Kappelhoff, 2005, British journal of clinical pharmacology.

An off-season outbreak of human metapneumovirus infections after ending of a COVID-19 lockdown

S. van Nieuwkoop, C. Linssen, E. V. van Gorp, 2022, Journal of Infection.

Is chronic HIV infection associated with venous thrombotic disease? A systematic review.

H. ten Cate, S. Klein, D. Brandjes, 2005, The Netherlands journal of medicine.

Identification and Profiling of Circulating Metabolites of Atazanavir, a HIV Protease Inhibitor

H. Rosing, R. Heine, M. Hillebrand, 2009, Drug Metabolism and Disposition.

High Treatment Uptake in Human Immunodeficiency Virus/Hepatitis C Virus–Coinfected Patients After Unrestricted Access to Direct-Acting Antivirals in the Netherlands

B. Berkhout, M. Wegdam, R. Meijering, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Is clinical outcome of dengue-virus infections influenced by coagulation and fibrinolysis? A critical review of the evidence.

H. ten Cate, A T A Mairuhu, M R Mac Gillavry, 2003, The Lancet. Infectious diseases.

Increased PAI-1 plasma levels and risk of death from dengue: no association with the 4G/5G promoter polymorphism

C. Hack, H. ten Cate, A. Leyte, 2005, Thrombosis journal.

Quantification of the HIV-integrase inhibitor raltegravir and detection of its main metabolite in human plasma, dried blood spots and peripheral blood mononuclear cell lysate by means of high-performance liquid chromatography tandem mass spectrometry.

H. Rosing, M. Hillebrand, R. ter Heine, 2009, Journal of pharmaceutical and biomedical analysis.

Quantification of etravirine (TMC125) in plasma, dried blood spots and peripheral blood mononuclear cell lysate by liquid chromatography tandem mass spectrometry.

H. Rosing, R. ter Heine, J. Beijnen, 2009, Journal of pharmaceutical and biomedical analysis.

Dengue: an arthropod-borne disease of global importance

J. Wagenaar, E. Gorp, D. Brandjes, 2004, European Journal of Clinical Microbiology and Infectious Diseases.